Technology is essential, but not all solutions meet every goal or offer the same capabilities.
Lisa Scholz, PharmD
Advertisement
Articles by Lisa Scholz, PharmD
What should covered entities do to prepare for increased reporting requirements?
Covered entities, government, and pharma companies could reach a compromise to benefit stakeholders.
Advertisement
Latest Updated Articles
340B Transparency: Is It "Transfairency"?January 28th 2020
340B Program Transparency: Is It "Transfairency"?March 28th 2020
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
5